Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a new class of drugs that might have a potential beneficial effect on bone metabolism. Data on the effect of GLP-1 RAs and fracture risk are lacking. The aim of the present study was to investigate the association between the use of GLP-1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Driessen, Johanna H. M., van Onzenoort, Hein A. W., Starup-Linde, Jakob, Henry, Ronald, Burden, Andrea M., Neef, Cees, van den Bergh, Joop P., Vestergaard, Peter, de Vries, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598352/
https://www.ncbi.nlm.nih.gov/pubmed/26184119
http://dx.doi.org/10.1007/s00223-015-0037-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598352/
https://www.ncbi.nlm.nih.gov/pubmed/26184119
http://dx.doi.org/10.1007/s00223-015-0037-y

Ejemplares similares